Birgitte Volck Appointed Non-Executive Director at OMass Therapeutics
Dr Birgitte Volck has over 25 years of industry experience spanning R&D leadership, platform innovation, and commercialization, with a strong focus on rare diseases and precision medicine.
DT Research Extends Comprehensive Medical Computing Line with DT514 All-in-One Computers
DT Research, the leading designer and manufacturer of purpose-built computing solutions for vertical markets, today introduced the DT514 series of All-in-One (AIO) medical computers specifically engineered to meet the demanding needs of in-room patient care. These Windows 11 IoT Enterprise and LTSC, Ubuntu, or IGEL OS models support strict healthcare compliance standards, such as HIPAA […]
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
The oversubscribed round was led by new investor HealthQuest Capital with support from existing OrganOx investors BGF and Lauxera Capital Partners, along with additional new investors Sofina, Soleus Capital, and Avidity Partners.
Co-Diagnostics Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
The decision by Co-Diagnostics to withdraw the submission was based on discussions with the FDA regarding the ability to detect a potential deterioration of one component of the test, related to shelf-life stability. Following dialogue with the FDA and exploring the various courses of action available, Co-Dx has determined that the best long-term solution would be to submit a version of the test that has been enhanced to address the matter raised in the 510(k) review process.
Philips and Mass General Brigham: Advancing Patient Care

Discover how Philips and Mass General Brigham are transforming healthcare with innovative AI solutions for better patient outcomes.
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
The Audiogene trial is designed to evaluate the safety, tolerability and efficacy of intra-cochlear injection of SENS-501 for the treatment of OTOF gene-mediated hearing loss in paediatric patients aged between 6 and 31 months at the time of gene therapy treatment. By targeting the first years of life, when brain plasticity is at its peak, the chances of these young children with pre-linguistic hearing loss of acquiring normal speech and language are maximised. The trial is comprised of two cohorts of two doses followed by an expansion cohort at the selected dose.
The Importance of Deburring in Modern Manufacturing | By Brett Mandes, LISSMAC Corporation

This article highlights the essential role of deburring in ensuring high-quality manufacturing outcomes and streamlining operations.
Buying E-Juice Like a Pro – Every Tip You Need to Know
Vaping is now a popular hobby among young people. Additionally, many smokers are switching to vaping, creating a large market for vaping devices and e-juices. If you are a vaping enthusiast, you know the importance of buying e-juice regularly. Some prefer to purchase in bulk, while others buy smaller quantities as needed. This article will […]
MG America Named Exclusive North American Distributor for Two Prominent Pharma Equipment Manufacturers

The new partnerships, both of which are effective immediately, further bolster MG America’s leadership status for its two main equipment categories: processing and packaging.
Suj Mehta Elevates TekniPlex Healthcare as New CEO

Suj Mehta assumes permanent leadership at a pivotal point in TekniPlex Healthcare’s evolution.
Seonix Bio Announces US Launch of SightScore, the First Commercially Available Clinical Polygenic Risk Score Testing Service for Glaucom
“I am incredibly pleased that we are able to make SightScore clinically available in the U.S., marking a significant advancement in the fight against glaucoma,” said Nick Haan, CEO, Seonix Bio.
Understanding Insurance Coverage for Drug Rehab

The path to recovery for those struggling with addiction is often complex and multifaceted, with insurance coverage playing a crucial role in accessing necessary treatment. Understanding the extent to which your insurance policy covers drug rehabilitation can alleviate financial concerns, allowing individuals to focus on their journey to sobriety. Comprehensive insurance policies may cover a […]